SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001683168-23-002060
Filing Date
2023-03-31
Accepted
2023-03-31 14:26:32
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-03-31

Document Format Files

Seq Description Document Type Size
1 NT 10-K sunshine_nt10k-123122.htm NT 10-K 20116
  Complete submission text file 0001683168-23-002060.txt   21423
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 001-41282 | Film No.: 23786651
SIC: 2834 Pharmaceutical Preparations